CD19 and acute lymphoblastic leukemia: Although there is no clear link between the costimulatory domain and neurological toxicity, anti-CD22 CAR T-cell for ALL exhibited a favorable neurotoxicity profile compared to that of anti-CD19 [23], and anti-BCMA displayed less frequent severe neurological toxicity [69,121].